Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Accumulated Expenses (2018 - 2025)

Dna X filings provide 8 years of Accumulated Expenses readings, the most recent being $704000.0 for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 181.6% to $704000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $704000.0, a 181.6% increase, with the full-year FY2025 number at $704000.0, up 181.6% from a year prior.
  • Accumulated Expenses hit $704000.0 in Q4 2025 for Dna X, down from $13.6 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $23.1 million in Q3 2024 to a low of $250000.0 in Q4 2024.
  • Median Accumulated Expenses over the past 5 years was $5.4 million (2021), compared with a mean of $7.2 million.
  • The widest YoY moves for Accumulated Expenses: up 5815.09% in 2024, down 97.97% in 2024.
  • Dna X's Accumulated Expenses stood at $836000.0 in 2021, then skyrocketed by 1178.95% to $10.7 million in 2022, then increased by 15.04% to $12.3 million in 2023, then crashed by 97.97% to $250000.0 in 2024, then surged by 181.6% to $704000.0 in 2025.
  • The last three reported values for Accumulated Expenses were $704000.0 (Q4 2025), $13.6 million (Q3 2025), and $12.2 million (Q2 2025) per Business Quant data.